Chinese General Practice ›› 2025, Vol. 28 ›› Issue (33): 4132-4139.DOI: 10.12114/j.issn.1007-9572.2024.0628
Special Issue: 心血管最新文章合辑
• Original Research • Previous Articles Next Articles
Received:
2024-11-04
Revised:
2025-05-20
Published:
2025-11-20
Online:
2025-09-17
Contact:
SU Haiyan
通讯作者:
苏海燕
作者简介:
作者贡献:
王碧优提出主要研究目标,负责研究的构思与设计,撰写文章初稿,对研究内容进行验证,保证研究结果的可重复性;高鹰、苏海燕负责文章的指导与修订;尤俊方、刘莉负责管理元数据、数据整理及维护;张卿负责文章的质量控制。
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2024.0628
组别 | 例数 | TG/HDL-C | TC/HDL-C | LDL-C/HDL-C | NLR | NMR | LMR | MHR | CRP(mg/L) |
---|---|---|---|---|---|---|---|---|---|
低危组 | 4 718 | 0.88(0.56,1.36) | 3.55(3.00,4.19) | 2.23(1.74,2.74) | 1.67(1.32,2.10) | 7.93(6.52,9.59) | 4.74(3.88,5.81) | 0.27(0.20,0.36) | 0.69(0.34,1.48) |
中危组 | 1 575 | 1.26(0.86,1.91) | 4.02(3.44,4.67) | 2.56(2.06,3.07) | 1.67(1.33,2.16) | 7.48(6.25,8.96) | 4.48(3.57,5.56) | 0.33(0.25,0.42) | 1.00(0.54,2.02) |
高危组 | 1 225 | 1.33(0.95,1.98) | 4.21(3.53,4.78) | 2.70(2.17,3.16) | 1.81(1.41,2.37) | 7.58(6.32,9.03) | 4.18(3.37,5.22) | 0.37(0.29,0.46) | 1.22(0.61,2.47) |
H值 | 684.12 | 550.39 | 421.29 | 48.82 | 57.81 | 170.65 | 613.21 | 333.74 | |
P值 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |
Table 1 Comparison of baseline characteristic in different 10-year ASCVD risk groups
组别 | 例数 | TG/HDL-C | TC/HDL-C | LDL-C/HDL-C | NLR | NMR | LMR | MHR | CRP(mg/L) |
---|---|---|---|---|---|---|---|---|---|
低危组 | 4 718 | 0.88(0.56,1.36) | 3.55(3.00,4.19) | 2.23(1.74,2.74) | 1.67(1.32,2.10) | 7.93(6.52,9.59) | 4.74(3.88,5.81) | 0.27(0.20,0.36) | 0.69(0.34,1.48) |
中危组 | 1 575 | 1.26(0.86,1.91) | 4.02(3.44,4.67) | 2.56(2.06,3.07) | 1.67(1.33,2.16) | 7.48(6.25,8.96) | 4.48(3.57,5.56) | 0.33(0.25,0.42) | 1.00(0.54,2.02) |
高危组 | 1 225 | 1.33(0.95,1.98) | 4.21(3.53,4.78) | 2.70(2.17,3.16) | 1.81(1.41,2.37) | 7.58(6.32,9.03) | 4.18(3.37,5.22) | 0.37(0.29,0.46) | 1.22(0.61,2.47) |
H值 | 684.12 | 550.39 | 421.29 | 48.82 | 57.81 | 170.65 | 613.21 | 333.74 | |
P值 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |
典型变量 | r值 | 特征值 | Wilks值 | F值 | P值 |
---|---|---|---|---|---|
1 | 0.569 | 0.478 | 0.668 | 217.551 | <0.001 |
2 | 0.100 | 0.010 | 0.988 | 11.789 | <0.001 |
3 | 0.049 | 0.002 | 0.998 | 6.041 | <0.001 |
Table 2 Canonical correlation analysis between lipid ratios and inflammatory markers
典型变量 | r值 | 特征值 | Wilks值 | F值 | P值 |
---|---|---|---|---|---|
1 | 0.569 | 0.478 | 0.668 | 217.551 | <0.001 |
2 | 0.100 | 0.010 | 0.988 | 11.789 | <0.001 |
3 | 0.049 | 0.002 | 0.998 | 6.041 | <0.001 |
变量 | U1 | U2 |
---|---|---|
X1(TG/HDL-C) | 1.172 | 1.998 |
X2(TC/HDL-C) | -1.274 | -3.984 |
X3(LDL-C/HDL-C) | 1.493 | 2.366 |
Table 3 The standardized correlation coefficient between lipid ratios and comprehensive variable of lipid ratios
变量 | U1 | U2 |
---|---|---|
X1(TG/HDL-C) | 1.172 | 1.998 |
X2(TC/HDL-C) | -1.274 | -3.984 |
X3(LDL-C/HDL-C) | 1.493 | 2.366 |
变量 | V1 | V2 |
---|---|---|
Y1(NLR) | -0.355 | 0.495 |
Y2(NMR) | 0.435 | 0.335 |
Y3(LMR) | 0.081 | -0.395 |
Y4(MHR) | 1.117 | 0.141 |
Y5(CRP) | 0.009 | -0.565 |
Table 4 The standardized correlation coefficient between inflammatory markers and comprehensive variable of inflammatory markers
变量 | V1 | V2 |
---|---|---|
Y1(NLR) | -0.355 | 0.495 |
Y2(NMR) | 0.435 | 0.335 |
Y3(LMR) | 0.081 | -0.395 |
Y4(MHR) | 1.117 | 0.141 |
Y5(CRP) | 0.009 | -0.565 |
分组 | 典型变量 | r值 | 特征值 | Wilks值 | F值 | P值 |
---|---|---|---|---|---|---|
低危组 | 1 | 0.573 | 0.490 | 0.661 | 140.403 | <0.001 |
2 | 0.110 | 0.012 | 0.984 | 9.263 | <0.001 | |
3 | 0.060 | 0.004 | 0.996 | 5.665 | 0.001 | |
中危组 | 1 | 0.552 | 0.439 | 0.680 | 43.178 | <0.001 |
2 | 0.142 | 0.020 | 0.979 | 4.166 | <0.001 | |
3 | 0.029 | 0.001 | 0.999 | 0.446 | 0.720 | |
高危组 | 1 | 0.496 | 0.326 | 0.739 | 25.898 | <0.001 |
2 | 0.135 | 0.019 | 0.980 | 3.059 | 0.002 | |
3 | 0.038 | 0.001 | 0.999 | 0.597 | 0.617 |
Table 5 Canonical correlation analysis between lipid ratios and inflammatory markers in different 10-year ASCVD risk groups
分组 | 典型变量 | r值 | 特征值 | Wilks值 | F值 | P值 |
---|---|---|---|---|---|---|
低危组 | 1 | 0.573 | 0.490 | 0.661 | 140.403 | <0.001 |
2 | 0.110 | 0.012 | 0.984 | 9.263 | <0.001 | |
3 | 0.060 | 0.004 | 0.996 | 5.665 | 0.001 | |
中危组 | 1 | 0.552 | 0.439 | 0.680 | 43.178 | <0.001 |
2 | 0.142 | 0.020 | 0.979 | 4.166 | <0.001 | |
3 | 0.029 | 0.001 | 0.999 | 0.446 | 0.720 | |
高危组 | 1 | 0.496 | 0.326 | 0.739 | 25.898 | <0.001 |
2 | 0.135 | 0.019 | 0.980 | 3.059 | 0.002 | |
3 | 0.038 | 0.001 | 0.999 | 0.597 | 0.617 |
分组 | 变量 | U1 | U2 |
---|---|---|---|
低危组 | X1(TG/HDL-C) | 1.111 | -1.913 |
X2(TC/HDL-C) | -1.446 | 5.599 | |
X3(LDL-C/HDL-C) | 1.633 | -4.029 | |
中危组 | X1(TG/HDL-C) | 1.582 | -2.193 |
X2(TC/HDL-C) | -1.576 | 3.744 | |
X3(LDL-C/HDL-C) | 1.592 | -2.029 | |
高危组 | X1(TG/HDL-C) | 1.016 | -1.105 |
X2(TC/HDL-C) | -0.565 | 1.122 | |
X3(LDL-C/HDL-C) | 0.925 | 0.011 |
Table 6 The standardized correlation coefficient between lipid ratios and comprehensive variable of lipid ratios in different 10-year ASCVD risk groups
分组 | 变量 | U1 | U2 |
---|---|---|---|
低危组 | X1(TG/HDL-C) | 1.111 | -1.913 |
X2(TC/HDL-C) | -1.446 | 5.599 | |
X3(LDL-C/HDL-C) | 1.633 | -4.029 | |
中危组 | X1(TG/HDL-C) | 1.582 | -2.193 |
X2(TC/HDL-C) | -1.576 | 3.744 | |
X3(LDL-C/HDL-C) | 1.592 | -2.029 | |
高危组 | X1(TG/HDL-C) | 1.016 | -1.105 |
X2(TC/HDL-C) | -0.565 | 1.122 | |
X3(LDL-C/HDL-C) | 0.925 | 0.011 |
分组 | 变量 | V1 | V2 |
---|---|---|---|
低危组 | Y1(NLR) | -0.264 | -0.388 |
Y2(NMR) | 0.370 | -0.377 | |
Y3(LMR) | 0.159 | 0.568 | |
Y4(MHR) | 1.099 | -0.145 | |
Y5(CRP) | 0.028 | 0.420 | |
中危组 | Y1(NLR) | -0.496 | 0.237 |
Y2(NMR) | 0.586 | -0.629 | |
Y3(LMR) | 0.035 | 1.206 | |
Y4(MHR) | 1.116 | -0.031 | |
Y5(CRP) | -0.039 | 0.119 | |
高危组 | Y1(NLR) | -0.602 | -0.994 |
Y2(NMR) | 0.644 | 0.224 | |
Y3(LMR) | -0.008 | -0.222 | |
Y4(MHR) | 1.110 | -0.188 | |
Y5(CRP) | -0.017 | 0.782 |
Table 7 The standardized correlation coefficient between inflammatory markers and comprehensive variable of inflammatory markers in different 10-year ASCVD risk groups
分组 | 变量 | V1 | V2 |
---|---|---|---|
低危组 | Y1(NLR) | -0.264 | -0.388 |
Y2(NMR) | 0.370 | -0.377 | |
Y3(LMR) | 0.159 | 0.568 | |
Y4(MHR) | 1.099 | -0.145 | |
Y5(CRP) | 0.028 | 0.420 | |
中危组 | Y1(NLR) | -0.496 | 0.237 |
Y2(NMR) | 0.586 | -0.629 | |
Y3(LMR) | 0.035 | 1.206 | |
Y4(MHR) | 1.116 | -0.031 | |
Y5(CRP) | -0.039 | 0.119 | |
高危组 | Y1(NLR) | -0.602 | -0.994 |
Y2(NMR) | 0.644 | 0.224 | |
Y3(LMR) | -0.008 | -0.222 | |
Y4(MHR) | 1.110 | -0.188 | |
Y5(CRP) | -0.017 | 0.782 |
[1] |
马丽媛,王增武,樊静,等. 《中国心血管健康与疾病报告2021》要点解读[J]. 中国全科医学,2022,25(27):3331-3346.
|
[2] |
|
[3] |
|
[4] |
|
[5] |
中国血脂管理指南修订联合专家委员会. 中国血脂管理指南(2023年)[J]. 中国循环杂志,2023,38(3):237-271. DOI:10.3969/j.issn.1000-3614.2023.03.001.
|
[6] |
郭才华,王启章,胡乔,等. 急性缺血性脑卒中患者脂肪因子Apelin、Vaspin、Leptin对出血转化的预测价值[J]. 心血管康复医学杂志,2021,30(3):269-273. DOI:10.3969/j.issn.1008-0074.2021.03.05.
|
[7] |
|
[8] |
|
[9] | |
[10] |
|
[11] |
李梦兰,梁宾,曹树正,等. 系统性炎症指数在冠心病中的临床意义及诊断价值研究[J]. 国际检验医学杂志,2021,42(19):2329-2332.
|
[12] |
|
[13] |
|
[14] |
|
[15] |
中国心血管病风险评估和管理指南编写联合委员会. 中国心血管病风险评估和管理指南[J]. 中国循环杂志,2019,34(1):4-28. DOI:10.3969/j.issn.1000-3614.2019.01.002.
|
[16] | |
[17] |
中国心血管病风险评估和管理指南编写联合委员会,顾东风. 中国心血管病风险评估和管理指南[J]. 中国循环杂志,2019,34(1):4-28. DOI:10.3760/cma.j.issn.0253-9624.2019.01.004.
|
[18] |
陈欣,王丹,刘佳莉,等. 不同风险预测模型评估高血压人群10年心血管疾病风险的比较[J]. 中华高血压杂志,2023,31(10):929-936. DOI:10.16439/j.issn.1673-7245.2023.10.008.
|
[19] |
陈瑞芳,黄俏,杨永红,等. 基于China-PAR模型正常高值血压与心血管病风险相关性研究[J]. 中国老年保健医学,2023,21(2):98-102.
|
[20] |
|
[21] |
|
[22] |
|
[23] |
董荣静,石柔,董雪娥,等. 中性粒细胞与淋巴细胞比值、血小板与淋巴细胞比值与2型糖尿病患者颈动脉粥样硬化的相关性[J]. 中华临床医师杂志(电子版),2017,11(2):179-182. DOI:10.3877/cma.j.issn.1674-0785.2017.02.001.
|
[24] |
|
[25] |
|
[26] |
|
[27] |
|
[28] |
|
[29] |
|
[30] |
张京. 外周血炎症指标与颈动脉粥样硬化的相关性研究[D]. 武汉:江汉大学,2023. DOI:10.27800/d.cnki.gjhdx.2023.000299.
|
[31] |
|
[32] |
|
[33] |
|
[34] |
|
[1] | ZHAO Zhuo, WANG He. Research Progress on the Mechanism of HIF-2α in Cardiovascular Diseases [J]. Chinese General Practice, 2025, 28(33): 4241-4248. |
[2] | XU Baichuan, WANG Yan, ZHANG Peng, LI Yiting, LIU Feilai, XIE Yang. Research and Analysis of Screening Tools for Chronic Obstructive Pulmonary Disease Comorbidity Lung Cancer [J]. Chinese General Practice, 2025, 28(30): 3847-3852. |
[3] | ZHOU Sheng, DENG Changsheng, ZOU Guanyang, SONG Jianping. Research Progress on the Pathogenesis of Complications of Malaria in Cardiovascular Diseases [J]. Chinese General Practice, 2025, 28(27): 3466-3472. |
[4] | SHAO Xiaoying, SHAO Jie, ZHU Yan, SHAO Jinling, SHANG Ling, WU Zhenlian, ZHAO Yu, ZHANG Jiacai. Analysis of the Current Status of Iron Deficiency and Factors Affecting Iron Deficiency Anemia among Children Aged 6-36 Months in Guizhou Province [J]. Chinese General Practice, 2025, 28(27): 3368-3374. |
[5] | XIANG Xinyue, ZHANG Bingqing, OUYANG Yuqin, TANG Wenjuan, FENG Wenhuan. Impact of Short-term Medical Weight Loss on Atherosclerotic Cardiovascular Disease Risk in Patients with Obesity [J]. Chinese General Practice, 2025, 28(26): 3229-3239. |
[6] | LIU Yinyin, SUI Hongping, LI Tingting, JIANG Tongtong, SHI Tieying, XIA Yunlong. Advances in Risk Prediction Models for Cardiotoxicity Associated with Breast Cancer Treatment [J]. Chinese General Practice, 2025, 28(24): 3072-3078. |
[7] | ZHOU Qian, WU Xiaomin, WANG Baohua, YAN Ruohan, YU Miao, WU Jing. Study on Nomogram Prediction Model for Risk of Gastric Cancer [J]. Chinese General Practice, 2025, 28(23): 2870-2877. |
[8] | GAO Haijun, REN Jiayu, WANG Ruolin, ZHOU Huiya, QU Peng. Research Progress on the Role of Endothelial Cell Injury and Dysfunction in Atherosclerosis [J]. Chinese General Practice, 2025, 28(21): 2697-2704. |
[9] | GUO Shengteng, ZHANG Fenfen, WAN Di, YU Dongmei, WANG Qinghua. Risk Factors for Severe Acute Pancreatitis Complicated with Acute Lung Injury: a Meta-analysis [J]. Chinese General Practice, 2025, 28(20): 2546-2554. |
[10] | CHU Tianyu, GU Yan. Carotid Artery Calcification Features in Plaque Stability and Clinical Events [J]. Chinese General Practice, 2025, 28(18): 2247-2252. |
[11] | PAN Yaojia, FU Fanglin, HAN Zheng, SUN Meng, GU Huaicong, WANG Weiqiang. Correlation of the Type of Obesity with the Cardiometabolic Multimorbidity: a Study in Male and Female Middle-aged Residents in Anhui Province [J]. Chinese General Practice, 2025, 28(18): 2285-2293. |
[12] | HAN Zheng, SUN Meng, FU Fanglin, PAN Yaojia, WANG Weiqiang. A Study on the Relationship between the Triglyceride-Glucose Index and Cardiometabolic Multimorbidity in Individuals Aged 50 and Above [J]. Chinese General Practice, 2025, 28(18): 2278-2284. |
[13] | ZHANG Bingqing, WANG Zhongkai, WU Changyong, SUN Huang, LI Ruijie, LIU Wenjie, LUO Yihua, ZHENG Lihui, PENG Yunzhu. Changes and Trend Prediction in the Global Burden of Congenital Heart Defects, 1990-2021 [J]. Chinese General Practice, 2025, 28(18): 2253-2261. |
[14] | AN Qinyu, WANG Yiying, ZHANG Xiaodan, ZHANG Tianlin, ZHAN Qingqing, ZHANG Fuyan, LIU Tao, WU Yanli. Prospective Cohort Study of the Impact of Socioeconomic Status and Healthy Lifestyle on Cardiovascular Disease [J]. Chinese General Practice, 2025, 28(16): 2017-2024. |
[15] | NIE Yuanyuan, FANG Da, XU Hao, YANG Donghui, BI Yan, GU Tianwei. Clinical Characteristics and Cardiovascular Disease Risk of Type 2 Diabetes Populations with Different Liver Fibrosis Risks [J]. Chinese General Practice, 2025, 28(15): 1847-1854. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||